Prognostic value of telomere length in acute coronary syndrome

Mechanisms of Ageing and Development

Volumn 133, Issue 11-12, 2012, Pages 695-697

  Perez Rivera, Jose Angel ^a   Pabon Osuna, Pedro ^a   Cieza Borrella, Clara ^b   Martin Herrero, Francisco ^a   Gonzalez Porras, Jose Ramon ^a   Gonzalez Sarmiento, Rogelio ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Acute coronary syndrome; Cardiovascular prognosis; Cellular ageing; Telomerase polymorphisms; Telomere length

Indexed keywords

TELOMERASE;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; DNA EXTRACTION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVASCULARIZATION; SMOKING; ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; TELOMERE HOMEOSTASIS;

ACUTE CORONARY SYNDROME; AGED; AGING; CARDIOVASCULAR DISEASES; CELL AGING; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; TELOMERASE; TELOMERE; TIME FACTORS;

EID: 84870739209     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2012.09.003     Document Type: Article

References (15)

1. Babizhayev M.A., Yegorov Y.E. Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large population-based cohort under the effect of smoking duration. Fundamental and Clinical Pharmacology 2011, 25:425-442.
2. Brouilette S.W., Moore J.S., McMahon A.D., Thompson J.R., Ford I., Shepherd J., Packard C.J., Samani N.J. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007, 369:107-114.
3. Calado R.T., Young N.S. Telomere diseases. New England Journal of Medicine 2009, 361:2353-2365.
4. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Research 2002, 30:e47.
5. Codd V., Mangino M., van der Harst P., Braund P.S., Kaiser M., Beveridge A.J., Rafelt S., Moore J., Nelson C., Soranzo N., Zhai G., Valdes A.M., Blackburn H., Mateo Leach I., de Boer R.A., Kimura M., Aviv A., Goodall A.H., Ouwehand W., van Veldhuisen D.J., van Gilst W.H., Navis G., Burton P.R., Tobin M.D., Hall A.S., Thompson J.R., Spector T., Samani N.J. Common variants near TERC are associated with mean telomere length. Nature Genetics 2010, 42:197-199.
6. de Vos-Houben J.M., Ottenheim N.R., Kafatos A., Buijsse B., Hageman G.J., Kromhout D., Giltay E.J. Telomere length, oxidative stress, and antioxidant status in elderly men in Zutphen and Crete. Mechanisms of Ageing and Development 2012, 133(6):373-377.
7. Donate L.E., Blasco M.A. Telomeres in cancer and ageing. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2011, 366:76-84.
8. Gil M.E., Coetzer T.L. Real-time quantitative PCR of telomere length. Molecular Biotechnology 2004, 27:169-172.
9. Jiang H., Schiffer E., Song Z., Wang J., Zurbig P., Thedieck K., Moes S., Bantel H., Saal N., Jantos J., Brecht M., Jeno P., Hall M.N., Hager K., Manns M.P., Hecker H., Ganser A., Dohner K., Bartke A., Meissner C., Mischak H., Ju Z., Rudolph K.L. Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:11299-11304.
10. Matsubara Y., Murata M., Yoshida T., Watanabe K., Saito I., Miyaki K., Omae K., Ikeda Y. Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochemical and Biophysical Research Communications 2006, 341:128-131.
11. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D., Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
12. Satoh M., Minami Y., Takahashi Y., Tabuchi T., Itoh T., Nakamura M. Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clinical Science (London) 2009, 116:827-835.
13. Testa R., Olivieri F., Sirolla C., Spazzafumo L., Rippo M.R., Marra M., Bonfigli A.R., Ceriello A., Antonicelli R., Franceschi C., Castellucci C., Testa I., Procopio A.D. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Diabetic Medicine 2011, 28:1388-1394.
14. Vulliamy T.J., Knight S.W., Mason P.J., Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells, Molecules, and Diseases 2001, 27:353-357.
15. Zee R.Y., Castonguay A.J., Barton N.S., Germer S., Martin M. Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study. Translational Research 2010, 155:166-169.